Bio Green Med Solution, Inc.BGMSEarnings & Financial Report
Nasdaq · Pharmaceutical Preparations
Revenue
$0
Gross Profit
N/A
Operating Profit
$-1.8M
Net Profit
$-3.1M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-284.21
Bio Green Med Solution, Inc. Q4 FY2024 Financial Summary
Bio Green Med Solution, Inc. reported revenue of $0 for Q4 FY2024, with a net profit of $-3.1M (up 42.1% YoY) (N/A margin).
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-3.1M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 FY2024 |
Bio Green Med Solution, Inc. Annual Revenue by Year
Bio Green Med Solution, Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $420.0K).
| Year | Annual Revenue |
|---|---|
| 2023 | $420.0K |
| 2022 | $0 |
Bio Green Med Solution, Inc. Quarterly Revenue & Net Profit History
Bio Green Med Solution, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $81.0K | +710.0% | $-988.0K | -1219.8% |
| Q4 FY2024 | $0 | — | $-3.1M | N/A |
| Q4 FY2023 | $31.0K | — | N/A | N/A |
| Q3 FY2023 | $16.0K | — | $-6.0M | -37700.0% |
| Q2 FY2023 | $373.0K | — | $-5.4M | -1460.6% |
| Q1 FY2023 | $0 | — | $-5.8M | N/A |
| Q4 FY2022 | $0 | — | $-7.4M | N/A |
| Q3 FY2022 | $0 | — | $-5.1M | N/A |
Income Statement
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $373000 | $16000 | $31000 | $0 | $81000 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 710.0% |
Balance Sheet
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $31.6M | $28.1M | $22.6M | $17.0M | $12.5M | $8.8M | $4.1M | $8.2M |
| Liabilities | $4.6M | $7.6M | $7.5M | $6.9M | $8.2M | $8.2M | $6.3M | $1.1M |
| Equity | $22.5M | $15.9M | $10.6M | $6.7M | $4.3M | $607000 | $-2.2M | $7.1M |
Cash Flow
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-7.0M | $-5.2M | $-6.9M | $-1.3M | $-4.0M | $-16.1M | $-1.4M | $-434000 |